Progress in Management of Mechanical Valve Thrombosis.

[1]  S. Gündüz,et al.  Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study. , 2022, Journal of the American College of Cardiology.

[2]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[3]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[4]  O. Gürsoy,et al.  Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. , 2015, American heart journal.

[5]  M. D. de Sousa,et al.  Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta‐analysis , 2014, Journal of thrombosis and haemostasis : JTH.

[6]  C. Çevik,et al.  Thrombolytic Therapy for the Treatment of Prosthetic Heart Valve Thrombosis in Pregnancy With Low-Dose, Slow Infusion of Tissue-Type Plasminogen Activator , 2013, Circulation.

[7]  G. Karthikeyan,et al.  Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. , 2013, European heart journal.

[8]  C. Çevik,et al.  Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. , 2013, JACC. Cardiovascular imaging.

[9]  P. Coste,et al.  Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. , 2009, Archives of cardiovascular diseases.